Labiotech.eu

News and Trends 10 Feb 2016

“Actelion could be the First European-born Biopharma to make it to the Major League”

This is what the founder & CEO Jean-Paul Clozel of Actelion (Switzerland) said at the announcement of the 2015 financial results for the company. And it’s definitely true. Actelion is the only European born biopharma to have over 1K employees (in fact over 2,547 of them). This is already a big achievement but not their greatest… For example, in 2015, […]

February 10, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 9 Feb 2016

When the Biggest Tech Investors Go Wild for Biotech

Biotech is catching new investors’ interest. Just in 2015, Google Ventures, the accelerator Y Combinator, Andreessen Horowitz (one of the most successful early-stage investment funds in the Valley) and Peter Thiel (founder of Paypal) showed their interest in Biotech. Why? And why now? Andreessen Horowitz is the investment fund created by Marc Andreessen (founder of Netscape) and […]

February 9, 2016 - 5 minutesmins - By Philip Hemme

deinove carotenoids synbio greentech deinochem

News and Trends 9 Feb 2016

Synthetic Biology Breakthrough in Production of Natural Carotenoids

The SynBio Biotech, Deinove (France), is hoping to break into the Carotenoid market for food, cosmetics and animal feed. Now, with their Deinococcus platform they have made several major advancements in their endeavours. Deinove also partnered with the Canadian company POS Bio-Sciences last year to try and kickstart the long-term project. Carotenoids are part of the isoprenoid family, which is the main area of […]

February 9, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Feb 2016

The European Union Finances the Future of CAR-T Manufacturing

CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes of Mortality in the Western world. Now this European consortium has amassed €6M for a more unified approach to CAR-T under a European Union Commission program. In response to this major health issue Miltenyi Biotec (Germany) coordinates the new EU-funded project […]

February 8, 2016 - 3 minutesmins - By Dani Bancroft

tedopi nsclc lung cancer ose pharma atlante

News and Trends 8 Feb 2016

French Biotech Launches Phase III Global Trial for Lung Cancer Drug

OSE Pharma (France) has initiated the US phase III trial, Atalante 1. This global, pivotal trial will evaluate Tedopi, the company’s lead product, for advanced non-small cell lung cancer (NSCLC). The phase III study was initiated in Europe in early 2016, so the screening of eligible patients diagnosed with non-small cell lung cancer is now actively ongoing in […]

February 8, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 8 Feb 2016

Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech

Here are 8 of the top European innovators under 30 which are part of the Biotech Ecosystem… After reading Forbes ’30 Under 30′ ranking in the Science and Healthcare field in Europe, we decided to list a few of these impressive individuals – one as young as 18 years old! The panel of judges was made up […]

February 8, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 7 Feb 2016

What happened this week? CRISPR, Microbiome, Algae in Biotech

Monday: Huge Milestone: UK Approves CRISPR Editing on Human Embryos Tuesday: Ultimate Review: The Unlimited Biotech Potential of Algae Wednesday: Meet the CEO of Europe’s Leading Microbiome Biotech Thursday: Zika Virus: Who in Biotech is Working to Stop its Spread? Friday: German RNA Specialist Could Break French Biotech into the Cancer Ecosystem Bonus: How we […]

February 7, 2016 - 1 minutemin - By Philip Hemme

News and Trends 5 Feb 2016

Biotech of the week: Effimune, the French Success-story in autoimmune disease

This week, we leave central Spain and head North-East, across the Pyrenees and head to the largest city in ‘Traditional Brittany’, France, and also the this week’s location, Nantes. This picturesque city was voted the most Green in EU (2013), is famous for the production of Muscadet wine and is home to our biotech of […]

February 5, 2016 - 2 minutesmins - By Philip Hemme

riboxx life sciences rna cancer tollys biotech

News and Trends 5 Feb 2016

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

Riboxx Life Sciences (Germany) has licensed out its drug development platform APOXXIM to a small biotech, Tollys SAS in Lyon (France) to investigate a specific type of cancer therapy. Riboxx develops customized and tailor-made molecular tools for gene silencing in vitro and in vivo through RNA interference via small interfering RNA (siRNA) and microRNA (miRNA). The company has two […]

February 5, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 4 Feb 2016

Zika Virus: Who in Biotech is Working to Stop its Spread?

The Zika virus epidemic could infect up to 4 Million people. As a cousin to Dengue Fever, what are the risks? Who in the Biotech and pharma world are working on a vaccine? And what is exactly this virus which has everyone hot and bothered? Literally meaning ‘overgrown‘ in the Luganda language, the Zika Virus name comes from the […]

February 4, 2016 - 4 minutesmins - By Nicolas Sainte-Foie

3d bioprinting brain neurology harvard inserm cnrs finland

News and Trends 4 Feb 2016

Finland, France and Harvard Bioprint Brains to Understand the 3D Structure

Researchers at Harvard University in collaboration with French and Finnish academic institutions have managed to 3D-bioprint a brain with the distinctive folds; An essential adaptation for our cognitive development. Harvard University worked with the CNRS at Aix Marseille Université (France), Institut Mines-Telecom INSERM (France) and the University of Jyväskylä (Finland). The team then published in Nature Physics what they discovered […]

February 4, 2016 - 3 minutesmins - By Dani Bancroft

Inside Labiotech 4 Feb 2016

How we Raised our First Seed Round to Build the Next TechCrunch for Biotech

You may have read it on Tech.eu (the biggest EU Startup blog), Gründerszene (the biggest German startup magazine) or in Maddyness (the biggest French Startup magazine) yesterday: Yes, we raised our first seed fundraising to become ‘the next TechCrunch’ for Biotech! The 6-figure seed round was raised with our lead investor WestTech Ventures as well as 4 European business […]

February 4, 2016 - 6 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

“Actelion could be the First European-born Biopharma to make it to the Major League”

When the Biggest Tech Investors Go Wild for Biotech

Synthetic Biology Breakthrough in Production of Natural Carotenoids

The European Union Finances the Future of CAR-T Manufacturing

French Biotech Launches Phase III Global Trial for Lung Cancer Drug

Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech

What happened this week? CRISPR, Microbiome, Algae in Biotech

Biotech of the week: Effimune, the French Success-story in autoimmune disease

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

Zika Virus: Who in Biotech is Working to Stop its Spread?

Finland, France and Harvard Bioprint Brains to Understand the 3D Structure

How we Raised our First Seed Round to Build the Next TechCrunch for Biotech

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!